Characterization of Two Potential Immunotherapeutics in Tumor Infiltrating Lymphocytes (TILs) Using Flow Cytometry and Meso Scale Discovery

June 9, 2018

Karen K. Yam¹, Stephen Parker², Michael Agrez², Christopher Warburton¹, Adriana Alcantara¹, Vicky Sgouroudis¹, and Jean-Francois Poulin¹. ¹Caprion Biosciences Inc., Montreal, Quebec, Canada. ²Inter-K Peptide Therapeutics, New South Wales, Australia

Download poster